Insulet's impressive growth with its Omnipod system, robust 2024 results, and surging valuation make it attractive. See more ...

Novo Nordisk extended a four-day winning streak on Friday, adding 5.18 percent to close at $88.08 apiece as investors cheered ...

UnitedHealth declines following a report that the Justice Department has been investigating the company’s Medicare billing ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the "Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...

UnitedHealth Group is under investigation by the Justice Department **over its Medicare billing prac ...

Stock indexes continued to bear the brunt of weak consumer sentiment as the trading week drew to a close Friday. The Dow Jones Industrial Average was hit hard as blue-chip UnitedHealth fell amid a ...

Co-Diagnostics (CODX) announced that, following a collaborative and informative dialogue with the Food and Drug Administration, the company has ...

The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.

Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in ...

Shares of Hims & Hers Health (NYSE: HIMS) are falling on Friday. The company's stock lost 23.2% as of 1 p.m. ET and lost as ...

With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine ...

Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...